Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Understanding of an aggregate probability statement by patients who are offered participation in Phase I clinical trials.

Weinfurt KP, Depuy V, Castel LD, Sulmasy DP, Schulman KA, Meropol NJ.

Cancer. 2005 Jan 1;103(1):140-7.

2.

The correlation between patient characteristics and expectations of benefit from Phase I clinical trials.

Weinfurt KP, Castel LD, Li Y, Sulmasy DP, Balshem AM, Benson AB 3rd, Burnett CB, Gaskin DJ, Marshall JL, Slater EF, Schulman KA, Meropol NJ.

Cancer. 2003 Jul 1;98(1):166-75.

3.

Understanding the attitudes of the elderly towards enrolment into cancer clinical trials.

Townsley CA, Chan KK, Pond GR, Marquez C, Siu LL, Straus SE.

BMC Cancer. 2006 Feb 8;6:34.

4.

Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication.

Meropol NJ, Weinfurt KP, Burnett CB, Balshem A, Benson AB 3rd, Castel L, Corbett S, Diefenbach M, Gaskin D, Li Y, Manne S, Marshall J, Rowland JH, Slater E, Sulmasy DP, Van Echo D, Washington S, Schulman KA.

J Clin Oncol. 2003 Jul 1;21(13):2589-96.

PMID:
12829680
5.

Lay public's understanding of equipoise and randomisation in randomised controlled trials.

Robinson EJ, Kerr CE, Stevens AJ, Lilford RJ, Braunholtz DA, Edwards SJ, Beck SR, Rowley MG.

Health Technol Assess. 2005 Mar;9(8):1-192, iii-iv.

6.

Communication with the patient in clinical research.

Zwitter M.

Ann N Y Acad Sci. 1997 Feb 20;809:83-96. No abstract available.

PMID:
9103560
7.
8.

Seeking informed consent to cancer clinical trials: describing current practice.

Brown RF, Butow PN, Ellis P, Boyle F, Tattersall MH.

Soc Sci Med. 2004 Jun;58(12):2445-57.

PMID:
15081196
9.

Physician-patient communication in phase I cancer trials.

Nitschke R.

J Clin Oncol. 2004 Feb 1;22(3):571-2; author reply 572-3. No abstract available.

PMID:
14752086
10.

Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training.

Brown RF, Butow PN, Boyle F, Tattersall MH.

Psychooncology. 2007 Jun;16(6):507-16.

PMID:
16986176
11.

Factors associated with participation in breast cancer treatment clinical trials.

Avis NE, Smith KW, Link CL, Hortobagyi GN, Rivera E.

J Clin Oncol. 2006 Apr 20;24(12):1860-7.

PMID:
16622260
14.

Must patients with advanced cancer choose between a Phase I trial and hospice?

Casarett DJ, Karlawish JH, Henry MI, Hirschman KB.

Cancer. 2002 Oct 1;95(7):1601-4.

15.

Patient participation in discussing palliative radiotherapy.

Timmermans LM, van der Maazen RW, Verhaak CM, van Roosmalen MS, van Daal WA, Kraaimaat FW.

Patient Educ Couns. 2005 Apr;57(1):53-61.

PMID:
15797153
16.

Factors that influence a patient's decision to participate in a phase I cancer clinical trial.

Schutta KM, Burnett CB.

Oncol Nurs Forum. 2000 Oct;27(9):1435-8.

PMID:
11058975
17.

Validation of the Subjective Numeracy Scale: effects of low numeracy on comprehension of risk communications and utility elicitations.

Zikmund-Fisher BJ, Smith DM, Ubel PA, Fagerlin A.

Med Decis Making. 2007 Sep-Oct;27(5):663-71.

PMID:
17652180
18.

When the treatment goal is not cure: are patients informed adequately?

Tattersall MH, Gattellari M, Voigt K, Butow PN.

Support Care Cancer. 2002 May;10(4):314-21. Retraction in: Support Care Cancer. 2011 Aug;19(8):1273.

PMID:
12029431
19.

Evaluation of an information booklet for patients considering participation in phase I clinical trials in cancer.

Hutchison C, Campbell S.

Eur J Cancer Care (Engl). 2002 Jun;11(2):131-8.

PMID:
12099949
20.

Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision.

Wright JR, Whelan TJ, Schiff S, Dubois S, Crooks D, Haines PT, DeRosa D, Roberts RS, Gafni A, Pritchard K, Levine MN.

J Clin Oncol. 2004 Nov 1;22(21):4312-8.

PMID:
15514372
Items per page

Supplemental Content

Support Center